ICON and University College Dublin Launch Innovative Graduate Certificate in Clinical Research
ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and the University College Dublin (UCD) School of Medicine & Medical Science today announced the launch of an innovative graduate certificate in clinical research that will enhance the quality of graduate training in clinical research and increase the pool of talent available to ICON to support their clients drug development programmes.
Available to life science graduates from September 2013, the 12-week programme combines industry-specific education and training with a parallel 12 week clinical-based internship in the UCD Clinical Research Centre at Dublin’s St Vincent’s and Mater Misericordiae University Hospitals. Education modules will include clinical trial management, data and project management, clinical research governance and ethics, and the clinical trial of the future.
Commenting on the launch, ICON’s CEO, Ciaran Murray, said: “ICON is a global leader in clinical research with over 10,000 employees worldwide and we are delighted to be collaborating with the UCD School of Medicine on this uniquely tailored programme to ensure that we develop the talent to support our future growth.”
Professor Patrick Murray, Dean of Medicine & Head, School of Medicine & Medical Science welcomed the collaboration with ICON noting: “this initiative further demonstrates the University’s growing links with industry. As Ireland’s leading academic clinical research facility, the UCD Clinical Research Centre has supported increasing numbers of investigator-led and industry-sponsored studies over the past six years. With more than 25,000 study-related patient contacts, the benefits to our patients are evident. Significant benefits to Ireland’s economy can also be realised as we train our graduates to conduct clinical and translational research to the highest international standards and prepare them for leadership roles within international clinical research organisations such as ICON.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
